These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39051609)

  • 1. Separable and controlled direct effects for competing events: Estimation of component specific effects on sickness absence.
    Maltzahn NN; Mehlum IS; Gran JM
    Stat Med; 2024 Jul; ():. PubMed ID: 39051609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating causal effects in the presence of competing events using regression standardisation with the Stata command standsurv.
    Syriopoulou E; Mozumder SI; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2022 Aug; 22(1):226. PubMed ID: 35963987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A generalized theory of separable effects in competing event settings.
    Stensrud MJ; Hernán MA; Tchetgen Tchetgen EJ; Robins JM; Didelez V; Young JG
    Lifetime Data Anal; 2021 Oct; 27(4):588-631. PubMed ID: 34468923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of separable direct and indirect effects in continuous time.
    Martinussen T; Stensrud MJ
    Biometrics; 2023 Mar; 79(1):127-139. PubMed ID: 34506039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal inference with recurrent and competing events.
    Janvin M; Young JG; Ryalen PC; Stensrud MJ
    Lifetime Data Anal; 2024 Jan; 30(1):59-118. PubMed ID: 37173588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A causal framework for classical statistical estimands in failure-time settings with competing events.
    Young JG; Stensrud MJ; Tchetgen Tchetgen EJ; Hernán MA
    Stat Med; 2020 Apr; 39(8):1199-1236. PubMed ID: 31985089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of separable direct and indirect effects in a continuous-time illness-death model.
    Breum MS; Munch A; Gerds TA; Martinussen T
    Lifetime Data Anal; 2024 Jan; 30(1):143-180. PubMed ID: 37270750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal inference in the face of competing events.
    Rudolph JE; Lesko CR; Naimi AI
    Curr Epidemiol Rep; 2020 Sep; 7(3):125-131. PubMed ID: 33747714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Prenatal Treatments on Offspring Events in the Presence of Competing Events: An Application to a Randomized Trial of Fertility Therapies.
    Chiu YH; Stensrud MJ; Dahabreh IJ; Rinaudo P; Diamond MP; Hsu J; Hernández-Díaz S; Hernán MA
    Epidemiology; 2020 Sep; 31(5):636-643. PubMed ID: 32501812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-competing events in dynamic regimes.
    Johnson BA
    Lifetime Data Anal; 2008 Jun; 14(2):196-215. PubMed ID: 17828622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-certification versus physician certification of sick leave for reducing sickness absence and associated costs.
    Kausto J; Verbeek JH; Ruotsalainen JH; Halonen JI; Virta LJ; Kankaanpää E
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013098. PubMed ID: 31087323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.
    Sapir-Pichhadze R; Pintilie M; Tinckam KJ; Laupacis A; Logan AG; Beyene J; Kim SJ
    Am J Transplant; 2016 Jul; 16(7):1958-66. PubMed ID: 26751409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods.
    Olarte Parra C; Daniel RM; Bartlett JW
    Stat Biopharm Res; 2023; 15(2):421-432. PubMed ID: 37260584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring mechanisms of action in clinical trials of complex surgical interventions using mediation analysis.
    Sharples L; Papachristofi O; Rex S; Landau S
    Clin Trials; 2020 Dec; 17(6):654-663. PubMed ID: 32815418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
    Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
    Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a national, voluntary agreement for a more inclusive working life on work participation following long-term sickness absence: a Norwegian cohort study.
    Hasting RL; Mehlum IS; Undem K; Robroek SJW; Burdorf A; Gran JM; Merkus SL
    Scand J Work Environ Health; 2023 Oct; 49(7):466-476. PubMed ID: 37548319
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.